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The post-extraction addition approach enables a quantitative assessment of ME, whatever their extent. On the other hand, only wide ME can be detected by the post-
column infusion approach. Finally, ME was compound and matrix dependent, and was corrected by the use of appropriate labeled IS, which were essential for a proper 
quantification of the analytes. 
Evaluation of matrix effects occuring during drugs of abuse 




In LC-MS/MS, some co-eluting components are susceptible to increase (ion enhancement) or reduce (ion suppression) the ionization of the target 
analytes, producing the so-called matrix effect (ME). The aim of the present work was to assess, by two approaches, the importance of ME during 
the quantitative determination of drugs of abuse in three biological matrices (serum, blood and oral fluid). 
The first strategy used to evaluate ME is the post-extraction 
addition [1] which involves the comparison of areas generated by 
the same amount of analyte, with and without the extracted matrix: 
• A = neat standard in the mobile phase 
• B = blank matrix extracted then spiked  
• Absolute ME (%) = B/A x 100 (can be corrected by the internal 
standard (IS)) 
• Relative ME (%) = CV (can be corrected by the internal standard) 
  
Both approaches were tested to evaluate ME of 3 biological fluids,  submitted to 2 distincts sample preparations and chromatographic conditions. 
Blood (n=20), serum (n=20) and oral fluid (n=15) specimens were tested. 
Cannabinoids: liquid-liquid extraction (hexane/ethyl acetate (9/1: v/v))  
Amphetamines, cocaine, opiates, opioids and metabolites: solid phase 
extraction (Oasis ® MCX 30mg, 1ml) 
 
UPLC Waters® Acquity → Quattro 
Premier QQQ MS (ESI) 
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Constant infusion 





Post-extraction addition Cannabinoids 
Example of post-
column infusion: when 
ME is significant, the 
signal variation is 
substantial (for this 
serum: ME=22%).  
Amphetamines, cocaine, opiates, opioids and metabolites 
Post-extraction addition 
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The second strategy used to evaluate ME is the post-column 
infusion [2] [3] which consists to monitor the detector response 
when an extracted matrix is injected during the continuing infusion 
of the target analyte: 





























THC 81 100 1.6 91 101 4.0 93 102 4.1 
THC-OH 125 100 1.1 109 103 4.1 N.d. N.d. N.d. 
THC-COOH 93 100 2.6 93 104 6.9 N.d. N.d. N.d. 
EDDP Rt 
Serum injection 
leading to ion 
suppression at 
the THC Rt 
THC Rt 
Mobile phase 
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Amphetamine 182 121 8.1 91 107 3.2 74 101 3.0 
Metamphetamine 154 109 3.7 80 103 3.8 64 98 6.0 
MDMA 166 94 5.2 93 100 3.7 51 98 2.7 
MDA 179 127 3.9 92 105 3.3 50 98 4.3 
MDEA 152 105 2.6 97 111 6.2 63 99 4.2 
MBDB 147 108 1.9 95 102 4.9 64 102 3.2 
Cocaine 117 99 1.3 93 108 3.6 88 102 1.5 
Benzoylecgonine 94 102 1.8 99 104 4.9 74 102 1.1 
Cocaethylene 81 100 1.4 100 106 3.5 N.d. N.d. N.d. 
Morphine 105 99 6.6 81 104 5.8 77 102 6.5 
6-MAM 129 114 4.3 134 95 3.2 83 101 3.7 
Codeine 144 108 2.8 201 99 2.6 145 101 2.3 
M6G 91 108 3.3 182 103 5.2 N.d. N.d. N.d. 
M3G 79 108 4.2 85 103 6.9 N.d. N.d. N.d. 
Hydromorphone 154 100 4.4 125 93 4.1 N.d. N.d. N.d. 
Dihydrocodeine 141 92 5.7 171 104 3.6 N.d. N.d. N.d. 
Hydrocodone 224 95 6.9 144 115 5.3 N.d. N.d. N.d. 
Oxycodone 254 102 3.1 164 88 3.7 N.d. N.d. N.d. 
Buprenorphine 42 92 5.8 58 100 7.8 N.d. N.d. N.d. 
Methadone 73 98 0.9 97 106 2.1 N.d. N.d. N.d. 
EDDP 76 97 1.5 89 99 5.3 N.d. N.d. N.d. 
Example of post-column infusion: 
when ME is significant, the signal 
variation is substantial (for this 
serum: ME=23%).  
Serum injection 
leading to ion 
suppression at 
the EDDP Rt 
Mobile phase 
N.d. = not determined 
Conclusion 
